← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Phoenix Children'S Hospital
Phoenix, AZ
$9,289,569
Total funding
6
Grants
Funding over time
peak $1.7M · FY2010–24$2M$1.5M$1M$500K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$9,289,569 · 6
By mechanism
U01$4,246,536 · 1
R01$2,531,661 · 2
U10$1,362,444 · 1
R21$699,502 · 1
K23$449,426 · 1
Investigators at Phoenix Children'S Hospital
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
All-Time
Most funded here, all years
Largest grants
Velopharyngeal insufficiency following cleft palate repair: a comparative effectiveness study of existing surgical procedures and identification of criteria to guide a personalized treatment approach$874,346
U01 · FY2023 · DE
Velopharyngeal insufficiency following cleft palate repair: a comparative effectiveness study of existing surgical procedures and identification of criteria to guide a personalized treatment approach$867,198
U01 · FY2022 · DE
Velopharyngeal insufficiency following cleft palate repair: a comparative effectiveness study of existing surgical procedures and identification of criteria to guide a personalized treatment approach$842,190
U01 · FY2020 · DE
Velopharyngeal insufficiency following cleft palate repair: a comparative effectiveness study of existing surgical procedures and identification of criteria to guide a personalized treatment approach$799,745
U01 · FY2024 · DE
Velopharyngeal insufficiency following cleft palate repair: a comparative effectiveness study of existing surgical procedures and identification of criteria to guide a personalized treatment approach$783,963
U01 · FY2021 · DE
A High-dose Folinic Acid Treatment for Core and Associated Symptoms of Autism$558,921
R01 · FY2018 · HD
A High-dose Folinic Acid Treatment for Core and Associated Symptoms of Autism$557,310
R01 · FY2019 · HD
A High-dose Folinic Acid Treatment for Core and Associated Symptoms of Autism$546,663
R01 · FY2020 · HD
A High-dose Folinic Acid Treatment for Core and Associated Symptoms of Autism$506,665
R01 · FY2021 · HD
CRCNS: Following the BOLD lightening at rest strikes the seizure onset zone!$362,102
R01 · FY2021 · NS
Predicting Morbidity from Pediatric Critical Care$286,175
U10 · FY2010 · HD
Preservation of Dried Plasma Spots for downstream proteomic applications$285,534
R21 · FY2014 · CA
Predicting Morbidity from Pediatric Critical Care$277,590
U10 · FY2011 · HD
Predicting Morbidity from Pediatric Critical Care$273,426
U10 · FY2012 · HD
Predicting Morbidity from Pediatric Critical Care$265,771
U10 · FY2014 · HD
Predicting Morbidity from Pediatric Critical Care$259,482
U10 · FY2013 · HD
Preservation of Dried Plasma Spots for downstream proteomic applications$244,820
R21 · FY2015 · CA
Preservation of Dried Plasma Spots for downstream proteomic applications$169,148
R21 · FY2016 · CA
Understanding and Reducing Variation in Outcomes of Cleft Lip and Palate Surgery$116,999
K23 · FY2019 · DE
Understanding and Reducing Variation in Outcomes of Cleft Lip and Palate Surgery$116,379
K23 · FY2020 · DE